1 completed, 1 recruiting, 1 terminated, 1 withdrawn. 2 Phase 1, 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Withdrawn 1 |
| Not applicable | 1 | Recruiting 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Stage IVB Prostate Cancer: new trials by email Literature Review of Stage IVB Prostate Cancer trials Research Report on Stage IVB Prostate Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 177Lu-PSMA-617 and Pembrolizumab in Treating Patients With Metastatic Castration-Resistant Prostate Cancer Lutetium Lu 177-PSMA-617, Pembrolizumab - Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma | Phase 1 | Completed | University of California, San Francisco | 43 | 2019-05-10 | 2025-02-25 |
| Nutrition and Exercise Interventions for Androgen Deprivation Therapy-Induced Obese Frailty in Elderly and Non-Elderly Survivors of Advanced Prostate Cancer Dietary Intervention, Educational Intervention, Exercise Intervention - Cancer Survivor, Obesity | Not applicable | Recruiting | Roswell Park Cancer Institute | 50 | 2019-05-02 | 2026-05-07 |
| Docetaxel or Abiraterone Acetate With ADT in Treating Patients With Metastatic Hormone Sensitive Prostate Cancer Abiraterone Acetate, Antiandrogen Therapy, Docetaxel - Castration-Sensitive Prostate Carcinoma, Metastatic Prostatic Adenocarcinoma | Phase 2 | Terminated | University of Utah | 1 | 2019-02-08 | 2020-06-25 |
| Stereotactic Body Radiation Therapy With REGN2810 and/or Ipilimumab Before Surgery in Treating Participants With Progressive Advanced or Oligometastatic Prostate Cancer Ipilimumab, Stereotactic Body Radiation Therapy (SBRT), Radical Prostatectomy - Stage III Prostate Cancer, Stage IIIA Prostate Cancer | Phase 1 | Withdrawn | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2018-12-24 | 2025-04-29 |
Prostatic Neoplasms (4) · Obesity (1) · Overweight (1)
Genital Diseases (4) · Genital Diseases, Male (4) · Genital Neoplasms, Male (4) · Male Urogenital Diseases (4) · Neoplasms (4) · Neoplasms by Site (4) · Prostatic Diseases (4) · Urogenital Diseases (4) · Urogenital Neoplasms (4) · Body Weight (1) · Nutrition Disorders (1) · Nutritional and Metabolic Diseases (1) · Overnutrition (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Abiraterone Acetate (1) · Androgen Antagonists (1) · CTLA-4 Antigen (1) · Diet Therapy (1) · Docetaxel (1) · Early Intervention, Educational (1) · Educational Status (1) · Ipilimumab (1) · Methods (1) · Pluvicto (1) · Prednisone (1) · Radiosurgery (1) · cemiplimab (1) · deltacortene (1) · pembrolizumab (1)
Roswell Park Cancer Institute (1) · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1) · University of California, San Francisco (1) · University of Utah (1)
United States (3)
Adam Dicker, MD (1) · Benjamin Maughan, MD (1) · Ellis Levine, MD (1) · Rahul Aggarwal, MD (1)
R01CA229354 (1)